Molecular Partners AG (MOLN) Tops Q4 EPS by 420c

Molecular Partners AG (NASDAQ: MOLN) reported Q4 EPS of $3.54, $4.20 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $189.6 million versus the consensus estimate of $4.52 million.

For earnings history and earnings-related data on Molecular Partners AG (MOLN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c